Table 2.
Results of Monte Carlo simulation analyses examining power to detect aim 1 and aim 2 outcome effects
| Outcome | Comparison (n per condition) | Predicted rates/effects | Power at α = .05 |
|---|---|---|---|
| Aim 1 | |||
| Reacha | Usual care (720)–preparation/implementation (480) | 2–22% | 98% |
| Adoptionb | Usual care (70)–preparation/implementation (70) | 10–50% | 95% |
| Implementation | No comparison | ||
| Maintenance | Preparation/implementation (480)–sustainment (1200) | ||
| Aim 2 | |||
| Stimulant abstinence | Usual care (720)–preparation/implementation (480) | 25–40% | 90% |
| Treatment retention | Usual care (720)–preparation/implementation (480) | 9 weeks–12 weeks | 94% |
Monte Carlo simulation multilevel power analyses featuring clustering in opioid treatment programs (anticipated ICC: 15%) and/or counselors (anticipated ICC: 10%)
aAssessed among patients nested in counselors and opioid treatment programs
bAsssessed among counselors nested in opioid treatment programs